- Home
- COEP vs CXAI Comparison
COEP vs CXAI Comparison
Compare COEP & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- CXAI
- Stock Information
- Founded
- COEP 2017
- CXAI N/A
- Country
- COEP United States
- CXAI United States
- Employees
- COEP N/A
- CXAI N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- CXAI EDP Services
- Sector
- COEP Health Care
- CXAI Technology
- Exchange
- COEP Nasdaq
- CXAI Nasdaq
- Market Cap
- COEP 62.4M
- CXAI 16.0M
- IPO Year
- COEP N/A
- CXAI N/A
- Fundamental
- Price
- COEP $12.60
- CXAI $0.72
- Analyst Decision
- COEP
- CXAI
- Analyst Count
- COEP 0
- CXAI 0
- Target Price
- COEP N/A
- CXAI N/A
- AVG Volume (30 Days)
- COEP 39.1K
- CXAI 630.4K
- Earning Date
- COEP 11-12-2025
- CXAI 11-11-2025
- Dividend Yield
- COEP N/A
- CXAI N/A
- EPS Growth
- COEP N/A
- CXAI N/A
- EPS
- COEP N/A
- CXAI N/A
- Revenue
- COEP $263,555.00
- CXAI $6,005,000.00
- Revenue This Year
- COEP N/A
- CXAI N/A
- Revenue Next Year
- COEP N/A
- CXAI $60.00
- P/E Ratio
- COEP N/A
- CXAI N/A
- Revenue Growth
- COEP N/A
- CXAI N/A
- 52 Week Low
- COEP $2.31
- CXAI $0.61
- 52 Week High
- COEP $14.70
- CXAI $2.54
- Technical
- Relative Strength Index (RSI)
- COEP 51.40
- CXAI 41.98
- Support Level
- COEP $12.09
- CXAI $0.70
- Resistance Level
- COEP $13.25
- CXAI $0.79
- Average True Range (ATR)
- COEP 0.73
- CXAI 0.05
- MACD
- COEP -0.12
- CXAI 0.01
- Stochastic Oscillator
- COEP 45.78
- CXAI 56.74
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.